Supportive strategies to improve adherence to IFN beta-1B in Multiple Sclerosis - Results of the BetaPlus observational cohort study

Journal of the Neurological Sciences

Volumn 307, Issue 1-2, 2011, Pages 120-126

  Pozzilli, Carlo ^a,e   Schweikert, Bernd ^b   Ecari, Ugo ^c   Oentrich, Wolfgang ^d   Benesova, Y ^e   Fiedler, J ^e   Meluzinova, E ^e   Novotna, A ^e   Pikova, J ^e   Albrecht, W ^e   Altmann, N ^e   Augspach Hofmann, R ^e   Berdermann Welz, S ^e   Blodau, A ^e   Bode, L ^e   Boer A ^e   Botzler, D ^e   Burkhardtde Boor, E ^e   Christopher, A ^e   Dieler, J ^e   Domke, S ^e   Eckhardt, U ^e   Eder, H ^e   Faiss, J ^e   Fegers, S ^e   Franz, P ^e   Freidel, M ^e   Haas, J ^e   Hackebeil, C ^e   Helfrich, S ^e   Herzog, S ^e   Hofmann, W ^e   Kafferlein W ^e   Kausch, U ^e   Kaya, B ^e   Korda, W ^e   Krumpolt, H ^e   Luber, G ^e   Maier, I ^e   Mamerow, U ^e   Mullner E ^e   Niedhammer, M ^e   Oschmann, P ^e   Ossig, W ^e   Peschel, S ^e   Piepenbrock, N ^e   Rauber, A ^e   Rauch, G ^e   Rohrer, G ^e   Rosenthal, A ^e   Ruther K ^e   Safavi, A ^e   Schlote, M ^e   Schnelzer, R ^e   Seifert, E ^e   Seybold, J ^e   Siefjediers, V ^e   Siever, A ^e   Veit, B ^e   Wietfeld, R ^e   Abbasyonn, T ^e   Abdoli, M ^e   Abolfazli, R ^e   Airemlou, H ^e   Alikhani, K ^e   Ashjazadeh, N ^e   Ashtari, F ^e   Azarangi, D ^e   Azarians, S ^e   Azimi, B ^e   Azimian, M ^e   Beladimoghadam, N ^e   Chitsaz, A ^e   Etemadyfar, M ^e   Farhoudi, M ^e   Fayaz Nekoo, M ^e   Ghadiri, F ^e   Ghazvinian, S ^e   Ghelich Nia Emrani, H ^e   Ghorbani, A ^e   Harirchian, M H ^e   Homam, M ^e   Ilkhani, M ^e   Khosravi, K ^e   Lotfi, J ^e   Malekzadeh, G ^e   Moshiri, Z ^e   Motamadi, M ^e   Motamed, M M ^e   Nabavi, S ^e   Nafissi, S ^e   Najlerahim, A ^e   Nikanfar, M ^e   Nikkhah, K ^e   Nikseresht, A ^e   Noorian, A ^e   Oraki, Z ^e   Pashapour, A ^e   Pourmahmoudian, H ^e   Saadatnia, M ^e   Sadeghi, H ^e   Sadreddini, S ^e   Saeidi, M ^e   Sahraian, M ^e   Salarjan, B ^e   Sasannezhad, P ^e   Seifi, J ^e   Shahbeigi, S ^e   Shahidi, M ^e   Shariat, A ^e   Shaygannejad, V ^e   Tabatabaei, M ^e   Togha, M ^e   Torabi, H ^e   Vosooghi, R ^e   Yousefi Azarfam, J ^e   Yousefipour, G ^e   Block, I ^e   Karni, A ^e   Karussis, D ^e   Kirshner, I ^e   Miller, A ^e   Milo, R ^e   Amato, M ^e   Annunziata, P ^e   Assetta, M ^e   Batocchi, A ^e   Brescia Morra, V ^e   Carbonin, C ^e   Carolei, A ^e   Catalan, M ^e   Cavallo, R ^e   Comi, G ^e   Coniglio, M ^e   Constantino, F ^e   Costantino, C ^e   Cottone, S ^e   Durelli, L ^e   Ferraro, E ^e   Ghezzi, A ^e   Gometto, B ^e   Grasso, M ^e   Greco, L ^e   Handouk, Y ^e   Iudice, A ^e   Koudriautseva, T ^e   Lugaresi, A ^e   Maimone, D ^e   Mannu, L ^e   Marchioretto, F ^e   Marrosu, M ^e   Meola, G ^e   Millefiorini, E ^e   Montanari, E ^e   Patti, F ^e   Pauri, F ^e   Plewnia, K ^e   Protti, A ^e   Reggio, A ^e   Rottoli, M ^e   Sinisi, L ^e   Spitaleri, D ^e   Tola, M R ^e   Abdallah, H ^e   Eid, H ^e   Ezzeddine, F ^e   Jbelly, S ^e   Khamis, C ^e   Koussa, S ^e   Masri, W ^e   Sawaya, R ^e   Serhan, A ^e   Shatila, A R ^e   Souklawi, K ^e   Sukkari, R ^e   Tfaily, H ^e   Traboulsi, H ^e   Wehbi, M ^e   Yamout, B ^e   Hadich, M S ^e   Baal, M G ^e   Dellemyn, P ^e   Driesen, J J M ^e   Timmerhues, T P J ^e   Valente, I ^e   AbdulJabar, M ^e   Cho, K H ^e   Kim, J W ^e   Sangdoe, Y ^e   Batue, J ^e   Ramio, L ^e   Benrabah, R ^e   Couur, B ^e   D'Gal, O ^e   Gras, P ^e   Guinot, H ^e   Lemarquis, P ^e   Munoz Lacoste, P ^e   Nayef, A ^e   Vaunaize, J ^e   Visy, J M ^e   Vongsouthi, C ^e   Chang, W N ^e   Tain Junn, C ^e   Yeh, S J ^e   Celebi, A ^e   Erdemoglu, A K ^e   Gedizlioglu, M ^e   Uysal Tan, F ^e   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IMS Health Economics and Outcomes Research   (Germany)

^c Medical Department   (Italy)

^d BAYER PHARMA AG   (Germany)

^e NONE   (Turkey)

Author keywords

Adherence; Autoinjector devices; Coping styles; Interferon beta 1b; Multiple Sclerosis; Nurses

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CYCLOPHOSPHAMIDE; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; MITOXANTRONE;

ADULT; ARTICLE; CLINICAL EVALUATION; COPING BEHAVIOR; DEPRESSION; DISABILITY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HEALTH PROGRAM; HUMAN; INFLUENZA; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SELF INJECTION; TREATMENT DURATION;

EID: 79959846501     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.04.026     Document Type: Article

References (33)

1. IFNB Multiple Sclerosis Study Group Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group Neurology 43 4 1993 Apr 655 661
2. D.W. Paty, and D.K. Li Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group Neurology 43 4 1993 Apr 662 667 (Pubitemid 23121952)
3. D. Paolicelli, V. Direnzo, and M. Trojano Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis Biologics 3 2009 369 376
4. A.P. Turner, D.R. Kivlahan, A.P. Sloan, and J.K. Haselkorn Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model Mult Scler 13 9 2007 Nov 1146 1152 (Pubitemid 351541418)
5. A. Lugaresi Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? Expert Opin Drug Deliv 6 9 2009 Sep 995 1002
6. S.C. Steinberg, R.J. Faris, C.F. Chang, A. Chan, and M.A. Tankersley Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study Clin Drug Investig 30 2 2010 89 100
7. M.G. Madonna, and M.M. Keating Multiple sclerosis pathways: an innovative nursing role in disease management J Neurosci Nurs 31 6 1999 Dec 332 335
8. A. While, A. Forbes, R. Ullman, and L. Mathes The role of specialist and general nurses working with people with multiple sclerosis J Clin Nurs 18 18 2009 Sep 2635 2648
9. N. Girouard, and G. Theoret Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis Can J Neurosci Nurs 30 4 2008 18 25
10. J. Rio, J. Porcel, N. Tellez, A. Sanchez-Betancourt, M. Tintore, and M.J. Arevalo Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis Mult Scler 11 3 2005 Jun 306 309 (Pubitemid 40775187)
11. K. Treadaway, G. Cutter, A. Salter, S. Lynch, J. Simsarian, and J. Corboy Factors that influence adherence with disease-modifying therapy in MS J Neurol 256 4 2009 Apr 568 576
12. M.P. McCabe, S. McKern, and E. McDonald Coping and psychological adjustment among people with multiple sclerosis J Psychosom Res 56 3 2004 Mar 355 361 (Pubitemid 38445087)
13. K. Lode, J.P. Larsen, E. Bru, G. Klevan, K.M. Myhr, and H. Nyland Patient information and coping styles in multiple sclerosis Mult Scler 13 6 2007 Jul 792 799 (Pubitemid 47074104)
14. T. Moreau, N. Schmidt, O. Joyeux, C. Bungener, and V. Souvignet Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatment Eur Neurol 62 2 2009 79 85
15. B. Brochet, G. Lemaire, and A. Beddiaf Reduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1b therapy with two different devices Rev Neurol (Paris) 162 6-7 2006 Jun 735 740 (Pubitemid 44046655)
16. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 11 1983 Nov 1444 1452 (Pubitemid 14237132)
17. S. Folkman, and R. Lazarus Manual for the ways of coping questionnaire 1988 Consulting Psychology Press Paolo Alto (CA)
18. D.F. Cella, K. Dineen, B. Arnason, A. Reder, K.A. Webster, and G. Karabatsos Validation of the functional assessment of multiple sclerosis quality of life instrument Neurology 47 1 1996 Jul 129 139 (Pubitemid 26243873)
19. L. Radloff The CES-D scale: a self-report depression for research in the general population Appl Psychol Meas 1 1977 385 401
20. D. Shinar, C.R. Gross, T.R. Price, M. Banko, P.L. Bolduc, and R.G. Robinson Screening for depression in stroke patients: the reliability and validity of the center for epidemiologic studies depression scale Stroke 17 2 1986 Mar 241 245 (Pubitemid 16125247)
21. R. Ghubash, T.K. Daradkeh, K.S. Al Naseri, N.B. Al Bloushi, and A.M. Al Daheri The performance of the Center for Epidemiologic Study Depression Scale (CES-D) in an Arab female community Int J Soc Psychiatry 46 4 2000 241 249 (Pubitemid 32094276)
22. S.A. Murrell, S. Himmelfarb, and K. Wright Prevalence of depression and its correlates in older adults Am J Epidemiol 117 2 1983 Feb 173 185 (Pubitemid 13194921)
23. H.L. Tremlett, and J. Oger Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS Neurology 61 4 2003 Aug 26 551 554 (Pubitemid 37025380)
24. K.E. O'Rourke, and M. Hutchinson Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns Mult Scler 11 1 2005 Feb 46 50 (Pubitemid 40259974)
25. E. Portaccio, V. Zipoli, G. Siracusa, S. Sorbi, and M.P. Amato Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis Eur Neurol 59 3-4 2008 131 135 (Pubitemid 351301255)
26. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 5 2005 Aug 4 487 497 (Pubitemid 41127293)
27. D.C. Mohr, A.C. Boudewyn, W. Likosky, E. Levine, and D.E. Goodkin Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject Ann Behav Med 23 2 2001 125 132 (Pubitemid 32488430)
28. V. Devonshire, Y. Lapierre, R. Macdonell, C. Ramo-Tello, F. Patti, and P. Fontoura The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis Eur J Neurol 2010 Jun 14
29. P. Bussfeld, and J. Czekalla Adherence to therapy in multiple sclerosis and schizophrenia Fortschr Neurol Psychiatr 78 3 2010 Mar 139 146
30. A. Forbes, A. While, L. Mathes, and P. Griffiths Evaluation of a MS specialist nurse programme Int J Nurs Stud 43 8 2006 Nov 985 1000 (Pubitemid 44515173)
31. N. Holland, P. Wiesel, P. Cavallo, C. Edwards, J. Halper, and R. Kalb Adherence to disease-modifying therapy in multiple sclerosis: part II Rehabil Nurs 26 6 2001 Nov 221 226
32. M.A. Chesney, T.B. Neilands, D.B. Chambers, J.M. Taylor, and S. Folkman A validity and reliability study of the coping self-efficacy scale Br J Health Psychol 11 Pt 3 2006 Sep 421 437 (Pubitemid 44342742)
33. K. Lode, E. Bru, G. Klevan, K.M. Myhr, H. Nyland, and J.P. Larsen Coping with multiple sclerosis: a 5-year follow-up study Acta Neurol Scand 2009 Dec 28